PARLIAMENT QUESTION: RESEARCH DEVELOPMENT AND INNOVATION SCHEME

Enough facts gathered (well beyond 4, all Tier-1 PIB). Writing note now.

1. At a Glance

2. Why in the News

3. Background & Evolution

4. Core Static Facts

Parameter Detail
Scheme name Research, Development and Innovation (RDI) Scheme
Outlay ₹1,00,000 crore over 6 years [S1]
Nodal/custodian body Special Purpose Fund (SPF) within Anusandhan National Research Foundation (ANRF) [S3]
Parent Act ANRF Act, 2023 (25 of 2023), in force from 5 Feb 2024 [S3]
Financing mode Long-term, low/nil-interest debt & equity, refinancing [S1][S2]
Delivery mechanism Second-Level Fund Managers (SLFMs) — Alternative Investment Funds (AIFs), Focused Research Organisations (FROs) [S1]
Eligibility threshold Projects at Technology Readiness Level (TRL) 4 and above [S1]
Sectoral scope "Strategic and Sunrise Domains" — sunrise & strategic sectors for innovation, tech adoption, competitiveness [S2]
Sanctions so far ₹1,000 crore each to Technology Development Board (TDB) and Biotechnology Industry Research Assistance Council (BIRAC) = ₹2,000 crore [S1][S4]
TDB project pipeline 22 projects; total cost ₹4,744 crore; RDI support ₹2,192 crore [S1][S4]
BIRAC project pipeline 8 projects shortlisted; ₹390.35 crore [S1][S4]
Related ministry Ministry of Science & Technology (DST) [S1]

5. Multi-Dimensional Analysis

Economic - Targets private-sector R&D financing gap — India's private R&D spend is historically low vs GDP; RDI seeks to crowd in private capital via patient/low-cost debt [S1][S2]. - Growth & risk capital framing signals venture-style de-risking of deep-tech, unlike traditional grant-only science funding [S2].

Scientific/Technological - TRL 4+ threshold targets post-lab, pre-commercial technologies — the classic "valley of death" between research and market [S1]. - Sectoral focus: biotech (BIRAC channel), broader Technology Development Board channel — cuts across strategic (defence-adjacent, semiconductors) and sunrise (AI, biotech, clean energy) domains [S2][S7].

Administrative/Governance - Two-tier structure (ANRF-SPF → SLFMs → end recipients) adds intermediation layers (AIFs/FROs) — introduces private fund-manager discretion into public R&D financing, a governance novelty worth scrutiny [S3][S1]. - Implementation split across multiple nodal agencies (TDB, BIRAC) under one umbrella scheme — coordination and monitoring challenge [S1][S4].

Legal/Constitutional - Statutory anchor is ANRF Act, 2023 — RDI Scheme itself is executive/Cabinet-approved, not separately legislated [S2][S3].

6. Recent Developments (last 12-18 months)

7. Prelims Hooks

8. Mains Relevance

9. Related Topics to Study Next

10. Common Errors / Trap Areas

11. Sources